Absence of birth defects in offspring of women treated with dactinomycin

Julianne Byrne, H. Stacy Nicholson, John J. Mulvihill

Research output: Contribution to journalLetter

2 Scopus citations

Abstract

To the Editor: In a study of birth defects among the offspring of survivors of cancer in childhood and adolescence, Green et al. (July 18 issue) found congenital heart disease in 2 of 20 children born to eight women who received dactinomycin as part of their anticancer therapy.1 To see whether we could replicate this unexpected finding, we determined the occurrence of birth defects among the offspring of similar survivors studied at five centers by the National Cancer Institute.2 , 3 None of the 52 offspring born to 36 survivors ( 11 men and 25 women) who had been treated with dactinomycin. . .

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume326
Issue number2
DOIs
StatePublished - Jan 9 1992

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Absence of birth defects in offspring of women treated with dactinomycin'. Together they form a unique fingerprint.

  • Cite this